Scarica l'app Stockscreener
0.3752
1.19%
-0.0045
Pre-mercato:
.37
-0.0052
-1.39%
Elevation Oncology Inc Borsa (ELEV) Ultime notizie
what makes elevation oncology inc. stock price move sharplySmart Trading With Safety Margin - Newser
Why Elevation Oncology Inc. stock attracts strong analyst attentionMomentum Buy Alert - beatles.ru
What makes Elevation Oncology Inc. stock price move sharplyWeekly Double Return List - Newser
How Elevation Oncology Inc. stock performs during market volatilityMulti Bagger Alerts - Newser
Elevation Oncology Terminates EO-3021 Study Amid Implications for Future Research and Development Strategies - AInvest
EO-3021 Study Termination: Implications for Elevation Oncology and Partners - TipRanks
Elevation Oncology ends license agreement with CSPC Megalith Biopharmaceutical - Investing.com
Elevation Oncology, Inc. (NASDAQ:ELEV) Receives $3.39 Average PT from Brokerages - Defense World
Analyzing Ratios: Elevation Oncology Inc (ELEV)’s Financial Story Unveiled - DWinneX
Elevation Oncology, Inc. (NASDAQ:ELEV) Sees Large Decline in Short Interest - Defense World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLS, ELEV, MTWO, CRKN on Behalf of Shareholders - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTCCRKN), Elevation Oncology, Inc. (NasdaqELEV), Sitio Royalties Corp. (NYSESTR), Vigil Neuroscience, Inc. (NasdaqV - TradingView
Research Analysts Set Expectations for ELEV FY2025 Earnings - Defense World
Q2 Earnings Estimate for ELEV Issued By Leerink Partnrs - Defense World
Equities Analysts Issue Forecasts for ELEV Q3 Earnings - Defense World
Wedbush Forecasts Reduced Earnings for Elevation Oncology - Defense World
Elevation Oncology (NASDAQ:ELEV) Cut to “Hold” at TD Cowen - Defense World
HC Wainwright Downgrades Elevation Oncology (NASDAQ:ELEV) to Neutral - Defense World
Elevation Oncology (NASDAQ:ELEV) Stock Rating Lowered by HC Wainwright - Defense World
Elevation Oncology (NASDAQ:ELEV) Downgraded by HC Wainwright to Neutral - Defense World
Elevation Oncology (NASDAQ:ELEV) Receives Market Perform Rating from JMP Securities - Defense World
Elevation Oncology (NASDAQ:ELEV) Lowered to Hold Rating by William Blair - Defense World
Elevation Oncology’s (ELEV) Neutral Rating Reaffirmed at HC Wainwright - Defense World
ELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevation Oncology, Inc.ELEV - Business Wire
Elevation Oncology (ELEV) Receives Analyst Rating Update | ELEV Stock News - GuruFocus
This McDonald's Analyst Turns Bearish; Here Are Top 4 Downgrades For Tuesday - Benzinga
Elevation Oncology (ELEV) Receives Downgrade from HC Wainwright & Co. | ELEV Stock News - GuruFocus
TD Cowen Downgrades Elevation Oncology to Hold From Buy - MarketScreener
HC Wainwright Downgrades Elevation Oncology to Neutral From Buy - marketscreener.com
Elevation Oncology (ELEV) Downgraded by H.C. Wainwright Amid Mer - GuruFocus
Elevation Oncology agrees to be acquired by Concentra - The Pharma Letter
Jane Street Group LLC Acquires 41,215 Shares of Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World
Millennium Management LLC Boosts Stock Holdings in Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World
Elevation Oncology agrees to Concentra Biosciences buyout By Investing.com - Investing.com South Africa
Elevation Oncology (ELEV) Downgraded Following Acquisition News - GuruFocus
Elevation Oncology (ELEV) Downgraded by William Blair Following Acquisition Announcement | ELEV Stock News - GuruFocus
Elevation Oncology (ELEV) to be Acquired by Concentra Biosciences | ELEV Stock News - GuruFocus
Concentra to acquire Elevation in bid to eliminate another biotech ‘zombie’ - BioPharma Dive
Elevation Oncology Accepts a Buyout Offer from Concentra Biosciences - marketscreener.com
Concentra Biosciences, LLC entered into a definitive merger agreement to acquire Elevation Oncology, Inc. for $21.4 million. - marketscreener.com
ELEV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Elevation Oncology, Inc. Is Fair to Shareholders - Business Wire
Elevation Oncology stock soars on Concentra merger agreement By Investing.com - Investing.com Nigeria
Elevation Oncology stock soars on Concentra merger agreement - Investing.com Australia
Concentra buys out another struggling Boston biotech - The Business Journals
0.64%
0.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):